Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark P. O'Connell is active.

Publication


Featured researches published by Mark P. O'Connell.


Molecular Cell | 1999

Triggering Cell Death: The Crystal Structure of Apo2L/TRAIL in a Complex with Death Receptor 5

Sarah G. Hymowitz; Hans W. Christinger; Germaine Fuh; Mark Ultsch; Mark P. O'Connell; Robert F. Kelley; Avi Ashkenazi; Abraham M. de Vos

Formation of a complex between Apo2L (also called TRAIL) and its signaling receptors, DR4 and DR5, triggers apoptosis by inducing the oligomerization of intracellular death domains. We report the crystal structure of the complex between Apo2L and the ectodomain of DR5. The structure shows three elongated receptors snuggled into long crevices between pairs of monomers of the homotrimeric ligand. The interface is divided into two distinct patches, one near the bottom of the complex close to the receptor cell surface and one near the top. Both patches contain residues that are critical for high-affinity binding. A comparison to the structure of the lymphotoxin-receptor complex suggests general principles of binding and specificity for ligand recognition in the TNF receptor superfamily.


Nature Biotechnology | 1991

FAB Assembly and Enrichment in a Monovalent Phage Display System

Lisa J. Garrard; Maria Yang; Mark P. O'Connell; Robert F. Kelley; Dennis J. Henner


Biochemistry | 2000

A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL.

Sarah G. Hymowitz; Mark P. O'Connell; Mark Ultsch; A. Hurst; K. Totpal; Avi Ashkenazi; A.M. de Vos; Robert F. Kelley


Nature | 2000

Peptide exosite inhibitors of factor VIIa as anticoagulants

Mark S. Dennis; Charles Eigenbrot; Nicholas J. Skelton; Mark Ultsch; Lydia Santell; Mary A. Dwyer; Mark P. O'Connell; Robert A. Lazarus


Biochemistry | 1993

Thermodynamic analysis of an antibody functional epitope.

Robert F. Kelley; Mark P. O'Connell


Biochemistry | 1992

Antigen binding thermodynamics and antiproliferative effects of chimeric and humanized anti-p185HER2 antibody fab fragments

Robert F. Kelley; Mark P. O'Connell; Paul Carter; Leonard G. Presta; Charles Eigenbrot; Michael Covarrubias; Brad Snedecor; James H. Bourell; David Vetterlein


Biochemistry | 1995

Analysis of the factor VIIa binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding.

Robert F. Kelley; Kimberly E. Costas; Mark P. O'Connell; Robert A. Lazarus


Protein Science | 1999

Antibody variable region binding by Staphylococcal protein A: Thermodynamic analysis and location of the Fv binding site on E‐domain

Melissa A. Starovasnik; Mark P. O'Connell; Wayne J. Fairbrother; Robert F. Kelley


Blood | 1997

A Soluble Tissue Factor Mutant Is a Selective Anticoagulant and Antithrombotic Agent

Robert F. Kelley; Canio J. Refino; Mark P. O'Connell; Nishit Modi; Pat Sehl; David G. Lowe; Cheryl Pater; Stuart Bunting


Biochemistry | 1996

Solution structure of the E-domain of staphylococcal protein A.

Melissa A. Starovasnik; Nicholas J. Skelton; Mark P. O'Connell; Robert F. Kelley; Dorothea Reilly; Wayne J. Fairbrother

Collaboration


Dive into the Mark P. O'Connell's collaboration.

Researchain Logo
Decentralizing Knowledge